Simultaneous determination of procalcitonin and interleukin-6 in human serum samples with a point-of-care biosensing device.
Dual-analyte assay
Interleukin-6
Multi area reflectance spectroscopy
Point-of-Care device
Procalcitonin
Journal
Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R
Informations de publication
Date de publication:
01 Jun 2023
01 Jun 2023
Historique:
received:
09
01
2023
revised:
17
02
2023
accepted:
27
02
2023
medline:
5
4
2023
pubmed:
9
3
2023
entrez:
8
3
2023
Statut:
ppublish
Résumé
The simultaneous determination of two inflammatory diseases biomarkers, namely procalcitonin (PCT) and interleukin-6 (IL-6), in human serum samples employing a Point-of-Care device based on Multi Area Reflectance Spectroscopy is presented. Dual-analyte detection was achieved using silicon chips with two silicon dioxide areas of different thickness, one functionalized with an antibody specific for PCT and the other with an antibody specific for IL-6. The assay included reaction of immobilized capture antibodies with mixtures of PCT and IL-6 calibrators with the biotinylated detection antibodies, streptavidin and biotinylated-BSA. The reader provided for the automated execution of the assay procedure, as well as for the collection and processing of the reflected light spectrum, the shift of which is correlated to analytes concentration in the sample. The assay was completed in 35 min and the detection limits for PCT and IL-6 were 2.0 and 0.01 ng/mL respectively. The dual-analyte assay was characterized by high reproducibility (the intra- and inter-assay coefficients of variation were less than 10% for both analytes) and accuracy (the percent recovery values ranged from 80 to 113% for both analytes). Moreover, the values determined for the two analytes in human serum samples with the assay developed were in good agreement with the values determined for the same samples by clinical laboratory methods. These results support the potential of the proposed biosensing device application for inflammatory biomarkers determination at the Point-of-Need.
Identifiants
pubmed: 36889192
pii: S0039-9140(23)00154-6
doi: 10.1016/j.talanta.2023.124403
pii:
doi:
Substances chimiques
Antibodies, Immobilized
0
Biomarkers
0
Interleukin-6
0
Procalcitonin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
124403Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Panagiota Petrou reports financial support was provided by European Regional Development Fund of the European Union and Greek national funds. Dimitra Tsounidi reports financial support was provided by Industrial Scholarships of Stavros Niarchos Foundation.